Goldman Sachs’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-156,113
| Closed | -$8.59M | – | 5953 |
|
|
2022
Q2 | $8.59M | Sell |
156,113
-284,892
| -65% | -$15.7M | ﹤0.01% | 2259 |
|
|
2022
Q1 | $14.1M | Buy |
+441,005
| New | +$14.1M | ﹤0.01% | 1960 |
|
|
2018
Q4 | – | Sell |
-1,014
| Closed | -$69K | – | 4316 |
|
|
2018
Q3 | $69K | Sell |
1,014
-2,879
| -74% | -$196K | ﹤0.01% | 4001 |
|
|
2018
Q2 | $461K | Buy |
3,893
+1,675
| +76% | +$198K | ﹤0.01% | 3558 |
|
|
2018
Q1 | $184K | Buy |
+2,218
| New | +$184K | ﹤0.01% | 3880 |
|
|
2017
Q1 | – | Sell |
-998
| Closed | -$59K | – | 4586 |
|
|
2016
Q4 | $59K | Buy |
998
+723
| +263% | +$42.7K | ﹤0.01% | 4212 |
|
|
2016
Q3 | $20K | Buy |
+275
| New | +$20K | ﹤0.01% | 4446 |
|
|
2016
Q2 | – | Sell |
-1,094
| Closed | -$295K | – | 4686 |
|
|
2016
Q1 | $295K | Buy |
1,094
+596
| +120% | +$161K | ﹤0.01% | 3556 |
|
|
2015
Q4 | $299K | Buy |
498
+66
| +15% | +$39.6K | ﹤0.01% | 3512 |
|
|
2015
Q3 | $354K | Buy |
+432
| New | +$354K | ﹤0.01% | 3508 |
|